RNA interference : challenges and therapeutic opportunities / edited by Mouldy Sioud.
RNA Interference: Challenges and Therapeutic Opportunities provides readers with recent advances in siRNA design, delivery, targeting, and methods to minimize siRNAâ€TMs unwanted effects. Preclinical and clinical use of synthetic siRNAs, the roles of miRNAs in cancer, and the promise of extracellul...
Saved in:
| Online Access: |
Full Text (via Springer) |
|---|---|
| Other Authors: | |
| Other title: | RNA interference (Humana Press) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York :
Humana Press : Springer,
[2015]
|
| Series: | Methods in molecular biology (Clifton, N.J.) ;
v. 1218. |
| Subjects: |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | in00000138939 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 141030t20152015nyua ob 001 0 eng d | ||
| 005 | 20240129204631.3 | ||
| 035 | |a (OCoLC)spr894067021 | ||
| 037 | |a spr978-1-4939-1538-5 | ||
| 040 | |a LGG |b eng |e rda |e pn |c LGG |d GW5XE |d SCB |d FTU |d YDXCP |d OCLCF |d OCLCQ |d QCL |d COO |d OCLCQ |d VT2 |d OCLCA |d MERER |d OCLCO |d TFH |d OCLCO |d OCLCA |d BUF |d CASUM |d OCLCQ |d U3W |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d UKMGB |d OCLCQ |d OCLCO |d OCLCQ |d WURST |d OCLCA |d LVT |d NLW |d OCLCO |d OCL |d OCLCQ |d WSU |d OCLCO | ||
| 015 | |a GBB8O2198 |2 bnb | ||
| 016 | 7 | |a 101647891 |2 DNLM | |
| 016 | 7 | |a 019177231 |2 Uk | |
| 019 | |a 898200253 |a 899273344 |a 902922248 |a 964870103 |a 967628581 |a 1005790237 |a 1228549558 |a 1229773126 | ||
| 020 | |a 9781493915385 |q (electronic bk.) | ||
| 020 | |a 149391538X |q (electronic bk.) | ||
| 020 | |z 9781493915378 | ||
| 020 | |z 1493915371 | ||
| 024 | 7 | |a 10.1007/978-1-4939-1538-5 |2 doi | |
| 029 | 1 | |a AU@ |b 000061110738 | |
| 029 | 1 | |a UKMGB |b 019177231 | |
| 035 | |a (OCoLC)894067021 |z (OCoLC)898200253 |z (OCoLC)899273344 |z (OCoLC)902922248 |z (OCoLC)964870103 |z (OCoLC)967628581 |z (OCoLC)1005790237 |z (OCoLC)1228549558 |z (OCoLC)1229773126 | ||
| 050 | 4 | |a QP623 | |
| 060 | 4 | |a W1 |b ME9616J v.1218 2015 | |
| 060 | 4 | |a QU 58.7 | |
| 049 | |a GWRE | ||
| 130 | 0 | |a RNA interference (Humana Press) | |
| 245 | 1 | 0 | |a RNA interference : |b challenges and therapeutic opportunities / |c edited by Mouldy Sioud. |
| 264 | 1 | |a New York : |b Humana Press : |b Springer, |c [2015] | |
| 264 | 4 | |c ©2015 | |
| 300 | |a 1 online resource (xvi, 495 pages) : |b illustrations (some colour) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file | ||
| 347 | |b PDF | ||
| 490 | 1 | |a Methods in Molecular Biology, |x 1940-6029 ; |v 1218 | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |t RNA interference : mechanisms, technical challenges, and therapeutic opportunities / |r Mouldy Sioud -- |t Nanostructured RNAs for RNA interference / |r Yuko Nakashima [and others] -- |t One long oligonucleotide or two short oligonucleotides based shRNA construction and expression / |r Xue-jun Wang and Sheng-qi Wang -- |t PLGA microspheres encapsulating siRNA / |r Giuseppe De Rosa and Giuseppina Salzano -- |t Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro / |r Olga Mykhaylyk [and others] -- |t Cytoplasmic delivery of siRNAs to monocytes and dendritic cells via electroporation / |r Mouldy Sioud -- |t Delivery of siRNAs to cancer cells via bacteria / |r Omar Ahmed, Andrea Krühn, and Hermann Lage -- |t Microwell array-mediated delivery of lipoplexes containing nucleic acids for enhanced therapeutic efficacy / |r Yun Wu, Daniel Gallego-Perez, and L. James Lee -- |t Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy / |r Karin Zins [and others] -- |t Targeted in vivo delivery of siRNA and an endosome- releasing agent to hepatocytes / |r Magdolna G. Sebestyén [and others] -- |t Cell-internalization SELEX : method for identifying cell- internalizing RNA aptamers for delivering siRNAs to target cells / |r William H. Thiel [and others] -- |t Strategies for siRNA navigation to desired cells / |r Mouldy Sioud -- |t Use of guanidinopropyl-modified siRNAs to silence gene expression / |r Maximilian C.R. Buff [and others] -- |t Therapy of respiratory viral infections with intranasal siRNAs / |r Sailen Barik and Patrick Lu -- |t Engineering therapeutic cancer vaccines that activate antitumor immunity / |r Per Ole Iversen and Mouldy Sioud -- |t Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses / |r Mouldy Sioud, Anne Mobergslien, and Stein Sæbøe-Larssen -- |t Targeting bcr-abl transcripts with siRNAs in an imatinib- resistant chronic myeloid leukemia patient : challenges and future directions / |r Michael Koldehoff -- |t Facile method for interfering with off-target silencing mediated by the sense strand / |r Anne Mobergslien and Mouldy Sioud -- |t Overcoming the challenges of siRNA activation of innate immunity : design better therapeutic siRNAs / |r Mouldy Sioud -- |t Gene silencing in vitro and in vivo using intronic microRNAs / |r Jia Han Deng [and others] -- |t In silico identification of novel endo-siRNAs / |r Andrew Schuster [and others] -- |t Computer-assisted annotation of small RNA transcriptomes / |r Nicole Ortogero [and others] -- |t miR-CATCH : microRNA capture affinity technology / |r Sebastian Vencken [and others] -- |t Roles of MicroRNAs in cancers and development / |r Shigeru Takasaki -- |t Targeting microRNAs to withstand cancer metastasis / |r Valentina Profumo [and others] -- |t Urinary microRNAs as a new class of noninvasive biomarkers in oncology, nephrology, and cardiology / |r Hana Mlcochova [and others] -- |t Magnetic bead-based isolation of exosomes / |r Morten P. Oksvold, Axl Neurauter, and Ketil W. Pedersen -- |t Modified 2'-ribose small RNAs function as toll-like receptor-7/8 antagonists / |r Mouldy Sioud. |
| 588 | 0 | |a Print version record. | |
| 520 | |a RNA Interference: Challenges and Therapeutic Opportunities provides readers with recent advances in siRNA design, delivery, targeting, and methods to minimize siRNAâ€TMs unwanted effects. Preclinical and clinical use of synthetic siRNAs, the roles of miRNAs in cancer, and the promise of extracellular miRNAs for diagnosis are also covered in this meticulous collection, along with novel methods for identifying endogenous siRNAs and the annotation of small RNA transcriptomes. Written for the highly successful Methods in Molecular Biology series, chapters include the kind of detail and key implementation advice that ensures successful results in the laboratory.  Comprehensive and cutting-edge, RNA Interference: Challenges and Therapeutic Opportunities will aid researchers, clinicians, teachers, and biotechnologists interested in the power of RNA-based therapies. | ||
| 650 | 0 | |a RNA. | |
| 650 | 0 | |a Gene silencing. | |
| 650 | 0 | |a RNA interference. | |
| 650 | 7 | |a RNA interference |2 fast | |
| 650 | 7 | |a Gene silencing |2 fast | |
| 650 | 7 | |a RNA |2 fast | |
| 700 | 1 | |a Sioud, Mouldy, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t RNA interference. |d New York : Humana Press ; Springer, ©2015 |z 9781493915378 |w (OCoLC)882189070 |
| 830 | 0 | |a Methods in molecular biology (Clifton, N.J.) ; |v v. 1218. |x 1064-3745 | |
| 856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-1-4939-1538-5 |z Full Text (via Springer) |
| 915 | |a - | ||
| 956 | |a Springer Protocols | ||
| 956 | |b Springer Nature - Complete Protocols | ||
| 998 | |b Added to collection springerlink.protocols | ||
| 994 | |a 92 |b COD | ||
| 999 | f | f | |s e6b90957-fa8c-4443-8cb4-6fdfdb0dbd6e |i 20af2d2b-af3d-44f7-b06f-5c31566b33c9 |
| 952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e QP623 |h Library of Congress classification |i web |